RF-Cemiplimab: First Drug Approved for the Treatment of Metastatic or Unresectable Cutaneous Squamous Cell Carcinoma

Autor: Morgado-Carrasco, D., Bosch-Amate, X., Fustà-Novell, X., Giavedoni, P. *
Zdroj: In Actas Dermo-Sifiliográficas (English Edition) March 2020 111(2):161-163
Databáze: ScienceDirect